www.sjpharma.com - home
BIDEX DMI
Dextromethorphan HBr 20 mg / Guaifenesin 400 mg
 BIDEX®-DMI Advantages

Immediate-release tablets
Known efficacy of trusted actives
Widely reimbursed

 Indications & Usage

  • Temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold
  • Helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive
 BIDEX®-DMI Contains

Dextromethorphan HBr 20 mg
Antitussive agent which has no analgesic or addictive properties.

Guaifenesin 400 mg
Expectorant which increases respiratory tract fluid secretions and helps loosen phlegm and bronchial secretions.

 
 Dosing and Administration

Adults and children 12 years of age and over: 1 tablet every 4 hours; not to exceed 6 tablets on 24 hours

 How Supplied

BIDEX®-DMI tablets are supplied as scored, dye-free, capsule-shaped tablets embossed with SJP 330 on one side and the other side is plain, in bottles of 100 tablets.

 
Downloads


BIDEX®-DMI Product Info

Product Detail Aid

Back to BIDEX® Family

BIDEX®-400 Tablets




Home | Corporate Info | Products | Regional Locations | Careers | Contact SJP